Search Page

1

Cite

Share

Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.

Van Gelder IC, Crijns HJ, Van Gilst WH, Van Wijk LM, Hamer HP, Lie KI. Van Gelder IC, et al. Among authors: van gilst wh, van wijk lm. Am J Cardiol. 1989 Dec 1;64(19):1317-21. doi: 10.1016/0002-9149(89)90574-2. Am J Cardiol. 1989. PMID: 2511744 Clinical Trial.

Cite

Share

2

Cite

Share

Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.

Hartog JW, Willemsen S, van Veldhuisen DJ, Posma JL, van Wijk LM, Hummel YM, Hillege HL, Voors AA; BENEFICIAL investigators. Hartog JW, et al. Among authors: van wijk lm, van veldhuisen dj. Eur J Heart Fail. 2011 Aug;13(8):899-908. doi: 10.1093/eurjhf/hfr067. Epub 2011 Jun 13. Eur J Heart Fail. 2011. PMID: 21669961 Free article. Clinical Trial.

Cite

Share

3

Cite

Share

Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial.

Willemsen S, Hartog JW, Hummel YM, Posma JL, van Wijk LM, van Veldhuisen DJ, Voors AA. Willemsen S, et al. Among authors: van wijk lm, van veldhuisen dj. Eur J Heart Fail. 2010 Mar;12(3):294-300. doi: 10.1093/eurjhf/hfp207. Epub 2010 Jan 25. Eur J Heart Fail. 2010. PMID: 20100811 Free article. Clinical Trial.

Cite

Share

4

Cite

Share

Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure.

Dunselman PH, Kingma JH, van Wijk LM, Dijk A, Wesseling H, Lie KI. Dunselman PH, et al. Among authors: van wijk lm. Drugs. 1985;29 Suppl 4:58-64. doi: 10.2165/00003495-198500294-00012. Drugs. 1985. PMID: 4006780

Cite

Share

5

Cite

Share

Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.

Tuininga YS, Crijns HJ, Oosterhuis B, Wiesfeld AC, van Wijk LM, Albronda F, de Bruin H, Jonkman JH, Kozma C, Lie KI. Tuininga YS, et al. Among authors: van wijk lm. J Cardiovasc Pharmacol. 1994 Mar;23(3):408-14. J Cardiovasc Pharmacol. 1994. PMID: 7515984 Clinical Trial.

Cite

Share

6

Cite

Share

Autonomic and hemodynamic effects of a new selective dopamine agonist, CHF1035, in patients with chronic heart failure.

Tjeerdsma G, van Wijk LM, Molhoek GP, Boomsma F, Haaksma J, van Veldhuisen DJ. Tjeerdsma G, et al. Among authors: van wijk lm, van veldhuisen dj. Cardiovasc Drugs Ther. 2001 Mar;15(2):139-45. doi: 10.1023/a:1011122929105. Cardiovasc Drugs Ther. 2001. PMID: 11669407 Clinical Trial.

Cite

Share

7

Cite

Share

Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade.

Tjeerdsma G, Szabó BM, van Wijk LM, Brouwer J, Tio RA, Crijns HJ, van Veldhuisen DJ. Tjeerdsma G, et al. Among authors: van wijk lm, van veldhuisen dj. Eur J Heart Fail. 2001 Jan;3(1):33-9. doi: 10.1016/s1388-9842(00)00119-7. Eur J Heart Fail. 2001. PMID: 11163733 Free article. Clinical Trial.

Cite

Share

8

Cite

Share

Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens.

Crijns HJ, van Wijk LM, van Gilst WH, Kingma JH, van Gelder IC, Lie KI. Crijns HJ, et al. Among authors: van gilst wh, van wijk lm, van gelder ic. Eur Heart J. 1988 Jun;9(6):634-8. doi: 10.1093/oxfordjournals.eurheartj.a062553. Eur Heart J. 1988. PMID: 3137061 Clinical Trial.

Cite

Share

9

Cite

Share

Abnormal pharmacokinetics of flecainide in a "nonresponder".

van Gelder IC, Crijns HJ, van Wijk LM, van Gilst WH, Lie KI. van Gelder IC, et al. Among authors: van gilst wh, van wijk lm. Clin Cardiol. 1988 May;11(5):353-5. doi: 10.1002/clc.4960110516. Clin Cardiol. 1988. PMID: 3133149 Free article.

Cite

Share

10

Cite

Share

Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome.

Crijns HJ, den Heijer P, van Wijk LM, Lie KI. Crijns HJ, et al. Among authors: van wijk lm. Am Heart J. 1988 Jun;115(6):1317-21. doi: 10.1016/0002-8703(88)90032-4. Am Heart J. 1988. PMID: 3132032 No abstract available.

Cite

Share